欢迎访问西安瑞禧生物技术有限公司官方网站

图片名

全国订购热线:
18966759382

首页 > 新闻资讯 > 市场活动

市场活动
行业新闻 市场活动 技术资讯

Fosaprepitant-d4 dimeglumine,福沙吡坦二甲葡胺-d4; MK-0517-d4; L785298-d4「同位素标记抑制剂」

作者:瑞禧生物 发布时间:2025-06-17 09:07:18 次浏览

生物活性:Fosaprepitant-d4 (dimeglumine) is deuterium labeled Fosaprepitant (dimeglumine). Fosaprepitant dimeglumine (MK-0517) is a proagent of Aprepitant (HY-10052). Fosaprepitant dimeglumine is a neurokinin-1 receptor antagonist, which is development for the prevention of chemotherapy-induced nausea and vomiting (CINV)[1].
体外研究(In Vitro):Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1].
瑞禧生物 has not independently confirmed the accuracy of these methods. They are for reference only.
Fosaprepitant-d4 dimeglumine 相关抗体:
NK1R Antibody
Substance P Antibody
Caspr2 Antibody (YA2970)
Caspr1 Antibody (YA3371)
分子量:1008.86
Formula:C37H52D4F7N6O16P
非标记 CAS:265121-04-8
中文名称:福沙吡坦二甲葡胺-d4
运输条件:Room temperature in continental US; may vary elsewhere.
储存方式:Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料
Data Sheet (533 KB)
产品使用指南 (1538 KB)
参考文献
[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216.
 [Content Brief]